↓ Skip to main content

PLOS

DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma

Overview of attention for article published in PLOS ONE, April 2012
Altmetric Badge

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
52 Mendeley
citeulike
1 CiteULike
Title
DW-MRI as a Biomarker to Compare Therapeutic Outcomes in Radiotherapy Regimens Incorporating Temozolomide or Gemcitabine in Glioblastoma
Published in
PLOS ONE, April 2012
DOI 10.1371/journal.pone.0035857
Pubmed ID
Authors

Stefanie Galbán, Benjamin Lemasson, Terence M. Williams, Fei Li, Kevin A. Heist, Timothy D. Johnson, Judith S. Leopold, Thomas L. Chenevert, Theodore S. Lawrence, Alnawaz Rehemtulla, Tom Mikkelsen, Eric C. Holland, Craig J. Galbán, Brian D. Ross

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
United States 1 2%
Brazil 1 2%
Unknown 49 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 23%
Researcher 11 21%
Student > Doctoral Student 7 13%
Professor > Associate Professor 4 8%
Student > Master 4 8%
Other 9 17%
Unknown 5 10%
Readers by discipline Count As %
Medicine and Dentistry 17 33%
Agricultural and Biological Sciences 8 15%
Biochemistry, Genetics and Molecular Biology 6 12%
Engineering 4 8%
Physics and Astronomy 3 6%
Other 7 13%
Unknown 7 13%